Skip to main content
Erschienen in: Inflammation 3/2011

01.06.2011

Imbalance Between Macrophage Migration Inhibitory Factor and Cortisol Induces Multiple Organ Dysfunction in Patients with Blunt Trauma

verfasst von: Mineji Hayakawa, Kenichi Katabami, Takeshi Wada, Yousuke Minami, Masahiro Sugano, Hidekazu Shimojima, Nobuhiko Kubota, Shinji Uegaki, Atsushi Sawamura, Satoshi Gando

Erschienen in: Inflammation | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Migration inhibitory factor (MIF) is associated with multiple organ dysfunction syndrome (MODS) in patients with systemic inflammatory response syndrome (SIRS). Our purposes were to determine the serum MIF, cortisol, and tumor narcosis factor-α (TNF-α) and to investigate the influences of the balance between the levels of MIF and cortisol in patients with blunt trauma. The cortisol levels were identical between the patients with and without MODS. However, the MIF and TNF-α levels in the patients with MODS were statistically higher than those of the patients without MODS. The cortisol/MIF ratios in the patients with MODS were statistically higher than those of the patients without MODS. The results show that MIF and TNF-α play an important role together in posttraumatic inflammatory response. An excessive serum MIF elevation overrides the anti-inflammatory effects of cortisol and leads to persistent SIRS followed by MODS in blunt trauma patients.
Literatur
1.
Zurück zum Zitat American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 20: 864–874.CrossRef American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 20: 864–874.CrossRef
2.
Zurück zum Zitat Malone, D.L., D. Kuhls, L.M. Napolitano, R. McCarter, and T. Scalea. 2001. Back to basics: Validation of the admission systemic inflammatory response syndrome score in predicting outcome in trauma. Journal of Trauma 51: 458–463.PubMedCrossRef Malone, D.L., D. Kuhls, L.M. Napolitano, R. McCarter, and T. Scalea. 2001. Back to basics: Validation of the admission systemic inflammatory response syndrome score in predicting outcome in trauma. Journal of Trauma 51: 458–463.PubMedCrossRef
3.
Zurück zum Zitat Nast-Kolb, D., M. Aufmkolk, S. Rucholtz, U. Obertacke, and C. Waydhas. 2001. Multiple organ failure still a major cause of morbidity but not mortality in blunt multiple trauma. Journal of Trauma 51: 835–841.PubMedCrossRef Nast-Kolb, D., M. Aufmkolk, S. Rucholtz, U. Obertacke, and C. Waydhas. 2001. Multiple organ failure still a major cause of morbidity but not mortality in blunt multiple trauma. Journal of Trauma 51: 835–841.PubMedCrossRef
4.
Zurück zum Zitat Napolitano, L.M., T. Ferrer, R.J. McCarter Jr., and T.M. Scalea. 2000. Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. Journal of Trauma 49: 647–652.PubMedCrossRef Napolitano, L.M., T. Ferrer, R.J. McCarter Jr., and T.M. Scalea. 2000. Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. Journal of Trauma 49: 647–652.PubMedCrossRef
5.
Zurück zum Zitat Bochicchio, G.V., L.M. Napolitano, M. Joshi, R.J. McCarter Jr., and T.M. Scalea. 2001. Systemic inflammatory response syndrome score at admission independently predicts infection in blunt trauma patients. Journal of Trauma 50: 817–820.PubMedCrossRef Bochicchio, G.V., L.M. Napolitano, M. Joshi, R.J. McCarter Jr., and T.M. Scalea. 2001. Systemic inflammatory response syndrome score at admission independently predicts infection in blunt trauma patients. Journal of Trauma 50: 817–820.PubMedCrossRef
6.
Zurück zum Zitat Rhen, T., and J.A. Cidlowski. 2005. Antiinflammatory action of glucocorticoids—New mechanisms for old drugs. New England Journal of Medicine 353: 1711–1723.PubMedCrossRef Rhen, T., and J.A. Cidlowski. 2005. Antiinflammatory action of glucocorticoids—New mechanisms for old drugs. New England Journal of Medicine 353: 1711–1723.PubMedCrossRef
7.
8.
Zurück zum Zitat Bloom, B.R., and B. Bennett. 1966. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153: 80–82.PubMedCrossRef Bloom, B.R., and B. Bennett. 1966. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153: 80–82.PubMedCrossRef
9.
Zurück zum Zitat Calandra, T., J. Bernhagen, C.N. Metz, L.A. Spiegel, M. Bacher, T. Donnelly, A. Cerami, and R. Bucala. 1995. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377: 68–71.PubMedCrossRef Calandra, T., J. Bernhagen, C.N. Metz, L.A. Spiegel, M. Bacher, T. Donnelly, A. Cerami, and R. Bucala. 1995. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377: 68–71.PubMedCrossRef
10.
Zurück zum Zitat Flaster, H., J. Bernhagen, T. Calandra, and R. Bucala. 2007. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Molecular Endocrinology 21: 1267–1280.PubMedCrossRef Flaster, H., J. Bernhagen, T. Calandra, and R. Bucala. 2007. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Molecular Endocrinology 21: 1267–1280.PubMedCrossRef
11.
Zurück zum Zitat Gando, S., J. Nishihira, S. Kobayashi, Y. Morimoto, S. Nanzaki, and O. Kemmotsu. 2001. Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome. Intensive Care Medicine 27: 1187–1193.PubMedCrossRef Gando, S., J. Nishihira, S. Kobayashi, Y. Morimoto, S. Nanzaki, and O. Kemmotsu. 2001. Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome. Intensive Care Medicine 27: 1187–1193.PubMedCrossRef
12.
Zurück zum Zitat Gando, S., A. Sawamura, M. Hayakawa, H. Hoshino, N. Kubota, and J. Nishihira. 2007. High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation. Inflammation 30: 118–124.PubMedCrossRef Gando, S., A. Sawamura, M. Hayakawa, H. Hoshino, N. Kubota, and J. Nishihira. 2007. High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation. Inflammation 30: 118–124.PubMedCrossRef
13.
Zurück zum Zitat Chuang, C.C., C.J. Hung, M.C. Tsai, T.M. Yeh, and Y.C. Chuang. 2004. High concentrations of circulating macrophage migration inhibitory factor in patients with severe blunt trauma: Is serum macrophage migration inhibitory factor concentration a valuable prognostic factor? Critical Care Medicine 32: 734–739.PubMedCrossRef Chuang, C.C., C.J. Hung, M.C. Tsai, T.M. Yeh, and Y.C. Chuang. 2004. High concentrations of circulating macrophage migration inhibitory factor in patients with severe blunt trauma: Is serum macrophage migration inhibitory factor concentration a valuable prognostic factor? Critical Care Medicine 32: 734–739.PubMedCrossRef
14.
Zurück zum Zitat Baker, S.P., B. O'Neill, W. Haddon Jr., and W.B. Long. 1974. The injury severity score: A method for describing patients with multiple injuries and evaluating emergency care. Journal of Trauma 14: 187–196.PubMedCrossRef Baker, S.P., B. O'Neill, W. Haddon Jr., and W.B. Long. 1974. The injury severity score: A method for describing patients with multiple injuries and evaluating emergency care. Journal of Trauma 14: 187–196.PubMedCrossRef
15.
Zurück zum Zitat Vincent, J.L., A. de Mendonca, F. Cantraine, R. Moreno, J. Takala, P.M. Suter, C.L. Sprung, F. Colardyn, and S. Blecher. 1998. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Critical Care Medicine 26: 1793–1800.PubMedCrossRef Vincent, J.L., A. de Mendonca, F. Cantraine, R. Moreno, J. Takala, P.M. Suter, C.L. Sprung, F. Colardyn, and S. Blecher. 1998. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Critical Care Medicine 26: 1793–1800.PubMedCrossRef
16.
Zurück zum Zitat Knaus, W.A., E.A. Draper, D.P. Wagner, and J.E. Zimmerman. 1985. APACHE II: A severity of disease classification system. Critical Care Medicine 13: 818–829.PubMedCrossRef Knaus, W.A., E.A. Draper, D.P. Wagner, and J.E. Zimmerman. 1985. APACHE II: A severity of disease classification system. Critical Care Medicine 13: 818–829.PubMedCrossRef
17.
Zurück zum Zitat Nishihira, J., Y. Koyama, and Y. Mizue. 1998. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 10: 199–205.PubMedCrossRef Nishihira, J., Y. Koyama, and Y. Mizue. 1998. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 10: 199–205.PubMedCrossRef
18.
Zurück zum Zitat Strieter, R.M., S.L. Kunkel, and R.C. Bone. 1993. Role of tumor necrosis factor-alpha in disease states and inflammation. Critical Care Medicine 21: S447–S463.PubMedCrossRef Strieter, R.M., S.L. Kunkel, and R.C. Bone. 1993. Role of tumor necrosis factor-alpha in disease states and inflammation. Critical Care Medicine 21: S447–S463.PubMedCrossRef
19.
Zurück zum Zitat Ozturk, H., Y. Yagmur, and H. Ozturk. 2008. The prognostic importance of serum IL-1beta, IL-6, IL-8 and TNF-alpha levels compared to trauma scoring systems for early mortality in children with blunt trauma. Pediatric Surgery International 24: 235–239.PubMedCrossRef Ozturk, H., Y. Yagmur, and H. Ozturk. 2008. The prognostic importance of serum IL-1beta, IL-6, IL-8 and TNF-alpha levels compared to trauma scoring systems for early mortality in children with blunt trauma. Pediatric Surgery International 24: 235–239.PubMedCrossRef
20.
Zurück zum Zitat Zedler, S., and E. Faist. 2006. The impact of endogenous triggers on trauma-associated inflammation. Current Opinion in Critical Care 12: 595–601.PubMedCrossRef Zedler, S., and E. Faist. 2006. The impact of endogenous triggers on trauma-associated inflammation. Current Opinion in Critical Care 12: 595–601.PubMedCrossRef
21.
Zurück zum Zitat Calandra, T., and R. Bucala. 1997. Macrophage migration inhibitory factor (MIF): A glucocorticoid counter-regulator within the immune system. Critical Reviews in Immunology 17: 77–88.PubMed Calandra, T., and R. Bucala. 1997. Macrophage migration inhibitory factor (MIF): A glucocorticoid counter-regulator within the immune system. Critical Reviews in Immunology 17: 77–88.PubMed
22.
Zurück zum Zitat Calandra, T., J. Bernhagen, R.A. Mitchell, and R. Bucala. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. Journal of Experimental Medicine 179: 1895–1902.PubMedCrossRef Calandra, T., J. Bernhagen, R.A. Mitchell, and R. Bucala. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. Journal of Experimental Medicine 179: 1895–1902.PubMedCrossRef
23.
Zurück zum Zitat Bernhagen, J., R.A. Mitchell, T. Calandra, W. Voelter, A. Cerami, and R. Bucala. 1994. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33: 14144–14155.PubMedCrossRef Bernhagen, J., R.A. Mitchell, T. Calandra, W. Voelter, A. Cerami, and R. Bucala. 1994. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33: 14144–14155.PubMedCrossRef
24.
Zurück zum Zitat Calandra, T., B. Echtenacher, D.L. Roy, J. Pugin, C.N. Metz, L. Hultner, D. Heumann, D. Mannel, R. Bucala, and M.P. Glauser. 2000. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nature Medicine 6: 164–170.PubMedCrossRef Calandra, T., B. Echtenacher, D.L. Roy, J. Pugin, C.N. Metz, L. Hultner, D. Heumann, D. Mannel, R. Bucala, and M.P. Glauser. 2000. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nature Medicine 6: 164–170.PubMedCrossRef
25.
Zurück zum Zitat Bacher, M., A. Meinhardt, H.Y. Lan, W. Mu, C.N. Metz, J.A. Chesney, T. Calandra, D. Gemsa, T. Donnelly, R.C. Atkins, and R. Bucala. 1997. Migration inhibitory factor expression in experimentally induced endotoxemia. American Journal of Pathology 150: 235–246.PubMed Bacher, M., A. Meinhardt, H.Y. Lan, W. Mu, C.N. Metz, J.A. Chesney, T. Calandra, D. Gemsa, T. Donnelly, R.C. Atkins, and R. Bucala. 1997. Migration inhibitory factor expression in experimentally induced endotoxemia. American Journal of Pathology 150: 235–246.PubMed
26.
Zurück zum Zitat Emonts, M., F.C. Sweep, N. Grebenchtchikov, A. Geurts-Moespot, M. Knaup, A.L. Chanson, V. Erard, P. Renner, P.W. Hermans, J.A. Hazelzet, and T. Calandra. 2007. Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clinical Infectious Diseases 44: 1321–1328.PubMedCrossRef Emonts, M., F.C. Sweep, N. Grebenchtchikov, A. Geurts-Moespot, M. Knaup, A.L. Chanson, V. Erard, P. Renner, P.W. Hermans, J.A. Hazelzet, and T. Calandra. 2007. Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clinical Infectious Diseases 44: 1321–1328.PubMedCrossRef
Metadaten
Titel
Imbalance Between Macrophage Migration Inhibitory Factor and Cortisol Induces Multiple Organ Dysfunction in Patients with Blunt Trauma
verfasst von
Mineji Hayakawa
Kenichi Katabami
Takeshi Wada
Yousuke Minami
Masahiro Sugano
Hidekazu Shimojima
Nobuhiko Kubota
Shinji Uegaki
Atsushi Sawamura
Satoshi Gando
Publikationsdatum
01.06.2011
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2011
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-010-9223-2

Weitere Artikel der Ausgabe 3/2011

Inflammation 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.